Faulding Healthcare

Faulding Healthcare, originally founded as F.H. Faulding & Co in 1845, was a premier Australian pharmaceutical company that achieved significant global scale in the generic medicines market. The company was particularly renowned for its expertise in the development and manufacture of generic injectable drugs, with a strong focus on oncology and pain management. In 2001, the company was acquired by Mayne Group in a multi-billion dollar deal, leading to the eventual separation of its pharmaceutical and healthcare distribution arms. Today, the Faulding brand continues to operate as a provider of over-the-counter products and generic pharmaceuticals under the ownership of the EBOS Group. The brand maintains a legacy of quality and reliability within the Australian healthcare system, supporting both hospital and retail pharmacy sectors.